These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19030859)

  • 1. Clinical efficacy of vorinostat in a patient with essential thrombocytosis and subsequent myelofibrosis.
    Lee J
    Ann Hematol; 2009 Jul; 88(7):699-700. PubMed ID: 19030859
    [No Abstract]   [Full Text] [Related]  

  • 2. [Management of adults presenting with a thrombocytosis].
    Viallard JF
    Rev Med Interne; 2010 Dec; 31 Suppl 3():S333-8. PubMed ID: 21035235
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of aspirin and clinical implications in essential thrombocythemia.
    Michiels JJ
    Semin Thromb Hemost; 2006 Sep; 32(6):646-8. PubMed ID: 16977575
    [No Abstract]   [Full Text] [Related]  

  • 4. 1,25-Dihydroxyvitamin D3 in the treatment of idiopathic thrombocythemia and myelofibrosis.
    Foa P; Maiolo AT; Cortellaro M; Ortolani S; Pogliani E; Deliliers GL; Iurlo A; Zocchi L; Gualdoni A; Polli E
    Haematologica; 1990; 75(3):294-5. PubMed ID: 2227630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.
    Zhan H; Spivak JL
    Clin Adv Hematol Oncol; 2009 May; 7(5):334-42. PubMed ID: 19521323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of vorinostat (MK-0683) in patients with primary myelofibrosis and post-polycythemia vera myelofibrosis.
    Andersen CL; Mortensen NB; Klausen TW; Vestergaard H; Bjerrum OW; Hasselbalch HC
    Haematologica; 2014 Jan; 99(1):e5-7. PubMed ID: 24425692
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant alpha 2 interferon in the treatment of chronic myeloproliferative disorders.
    Bonaccorso R; Teresi M; Gebbia V; Tambone Reyes M; Tinnirello D; Di Marco P; Citarrella P; Mansueto S
    J Chemother; 1989 Jul; 1(4 Suppl):1266-8. PubMed ID: 16312860
    [No Abstract]   [Full Text] [Related]  

  • 8. Telomerase Inhibitor Imetelstat in Essential Thrombocythemia and Myelofibrosis.
    Tefferi A
    N Engl J Med; 2015 Dec; 373(26):2580-1. PubMed ID: 26709404
    [No Abstract]   [Full Text] [Related]  

  • 9. Telomerase Inhibitor Imetelstat in Essential Thrombocythemia and Myelofibrosis.
    Bjørn ME; Nielsen CH; Hasselbalch HC
    N Engl J Med; 2015 Dec; 373(26):2579-80. PubMed ID: 26699178
    [No Abstract]   [Full Text] [Related]  

  • 10. [Primary myelofibrosis (osteomyelosclerosis). Current views on the pathogenesis, clinical course, diagnosis and therapy].
    Demidova AV
    Ter Arkh; 1974; 46(8):19-29. PubMed ID: 4422055
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-dose thalidomide in myelofibrosis.
    Weinkove R; Reilly JT; McMullin MF; Curtin NJ; Radia D; Harrison CN
    Haematologica; 2008 Jul; 93(7):1100-1. PubMed ID: 18508796
    [No Abstract]   [Full Text] [Related]  

  • 12. Leukonychia related to vorinostat.
    Anderson KA; Bartell HL; Olsen EA
    Arch Dermatol; 2009 Nov; 145(11):1338-9. PubMed ID: 19917975
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy.
    Palandri F; Catani L; Testoni N; Ottaviani E; Polverelli N; Fiacchini M; De Vivo A; Salmi F; Lucchesi A; Baccarani M; Vianelli N
    Am J Hematol; 2009 Apr; 84(4):215-20. PubMed ID: 19208420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential thrombocythemia in a child with elevated thrombopoietin concentrations and skeletal anomalies.
    Robins EB; Niazi M
    Pediatr Blood Cancer; 2008 Apr; 50(4):859-61. PubMed ID: 17455310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term remission of non-Hodgkin lymphoma secondary to the treatment for essential thrombocythemia].
    Kubota Y; Waki M
    Rinsho Ketsueki; 2009 Mar; 50(3):197-202. PubMed ID: 19352088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vorinostat for the treatment of bullous pemphigoid in the setting of advanced, refractory cutaneous T-cell lymphoma.
    Gardner JM; Evans KG; Goldstein S; Kim EJ; Vittorio CC; Rook AH
    Arch Dermatol; 2009 Sep; 145(9):985-8. PubMed ID: 19770436
    [No Abstract]   [Full Text] [Related]  

  • 17. Treating Myeloproliferation--On Target or Off?
    Armanios M; Greider CW
    N Engl J Med; 2015 Sep; 373(10):965-6. PubMed ID: 26332552
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment procedures in myelofibrosis].
    Klimova NF
    Probl Gematol Pereliv Krovi; 1978; 23(11):31-5. PubMed ID: 714890
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thrombocytosis and essential thrombocythemia in childhood].
    Mialou V; Kagialis-Girard S; Galambrun C; Pondarré C; Kebaili K; Ffrench M; Pagès MP; Bertrand Y
    Arch Pediatr; 2005 Aug; 12(8):1249-54. PubMed ID: 15908186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [10-years experience with myelobromol treatment of myelofibrosis].
    Klimova NF
    Haematologia (Budap); 1977; 11(1-2):57-72. PubMed ID: 615089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.